On December 10, Deutsche Bank analyst George Hill raised the firm’s price target on McKesson Corporation (NYSE:MCK) to $904 from $861 and kept a Buy rating on the shares. In a research note, the ...

In healthcare, every decision matters — from how products are ordered to how inventory is managed and budgets are allocated. But in today’s complex, data-driven environment, many organizations ...

In ordering the additional discovery, U.S. District Judge Nina Gershon pointed out that McKesson—represented by Covington & Burling—had told U.S. Magistrate Judge Steven Tiscione “in the strongest ...

Curious if McKesson is currently a bargain, or if the impressive run has left little value on the table? Let’s explore what is influencing opinions on its price and consider the factors that may shape ...

McKesson’s CEO Brian Tyler and other leaders have emphasized AI’s role in driving efficiency and growth. The company has strengthened its AI infrastructure through key partnerships and acquisitions, ...

(Reuters) -Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses. Shares of the company ...

Sept 23 (Reuters) - McKesson (MCK.N), opens new tab on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth ...

IRVING, Texas--(BUSINESS WIRE)-- McKesson Corporation (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026.

In the latest trading session, McKesson (MCK) closed at $719.80, marking a +1.92% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.85%. Meanwhile, the ...

McKesson Corp. and Rx Savings were named in a breach of employment contract lawsuit on Sept. 4 in Kansas 10th Judicial District Court for Johnson County. The complaint, which arises from McKesson's ...

McKesson is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $300 billion in sales, the firm supplies roughly a third of the domestic ...

Aug 6 (Reuters) - U.S. drug distributor McKesson (MCK.N), opens new tab raised its annual profit forecast and beat Wall Street earnings estimates on Wednesday, banking on robust demand for specialty ...